Skip to Main Content

Clinical Studies and Protocols

Site Map Investigators Log-in
(TCZ-0836) Food and AD

 Return to List of Clinical Studies
 Return to List of Protocols for Psoriasis and Skin Diseases
Food Allergy, Phenotype, Regulation and Development of the Immune System in Adult Atopic Dermatitis Patients

Principal Investigator:
Tali Czarnowicki


Contact Information:
Recruitment Specialist
1230 York Avenue
New York, NY 10065
Telephone: 1800RUCARES
Alt. Telephone: 1800RUCARES
Enrollment Status:

Brief Summary of Protocol:
Atopic dermatitis (AD), which is also known as eczema, is a common chronic, relapsing skin condition associated with intense skin itching and rash, which can impact most aspects of everyday life. The exact cause of the disease is not fully known, but it involves an imbalance of the immune system as well as skin barrier impairment. Several environmental factors have been described to worsen eczema. These include irritants, foods and environmental allergens. The relationship between food allergies and atopic eczema is not understood. This study hopes to improve our understanding of how the immune system acts in eczema, allergic skin responses to foods and the relationship between food and eczema in adult patients. Hopefully, the results will increase our knowledge of the relationship between food allergies and eczema and lead to medical treatment development.

Detailed Description of Protocol:

What specifically makes a person eligible for the study?
You may be eligible to enter this study:

1) Group 1: individuals must have eczema 2) Group 2: have a known/ suspected food allergy, and do not experience anaphylaxis 3) Cannot be HIV positive 4) Cannot be pregnant 5) Cannot have a history of asthma



Children permitted to participate:

Potential Benefits.....
You will have prick tests, patch tests, and blood tests that may identify the particular allergens that cause you to develop the rash of eczema. You will be educated regarding how to avoid these allergens and you may be referred for treatment for the eczema.

compensation is provided